Page last updated: 2024-09-04

cinacalcet and Anemia

cinacalcet has been researched along with Anemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Micozkadioglu, H; Nursal, GN; Ozelsancak, R; Torun, D; Yigit, F; Yildiz, I1
Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Ito, K; Matsushita, K; Tanaka, M; Yoshida, K1
Erickson, KF; Winkelmayer, WC1
Okimoto, N; Oshiro, Y; Tanaka, H1
Bargman, JM; Battistella, M; Chan, CT; Richardson, RM1
Cases, A2

Reviews

1 review(s) available for cinacalcet and Anemia

ArticleYear
Update in nephrology. Highlights from the 36th Annual Meeting of the American Society of Nephrology.
    Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40, Issue:1

    Topics: Anemia; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Congresses as Topic; Diabetic Nephropathies; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Nephrology

2004

Other Studies

6 other study(ies) available for cinacalcet and Anemia

ArticleYear
The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2016, Volume: 27, Issue:1

    Topics: Anemia; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Pilot Projects; Prospective Studies; Renal Dialysis

2016
Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Aged; Anemia; Calcimimetic Agents; Calcitriol; Case-Control Studies; Cinacalcet; Diabetes Complications; Female; Follow-Up Studies; Glomerulonephritis; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Parathyroid Hormone; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome

2016
The challenges of cost-effectiveness analyses for the clinician.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:6

    Topics: Anemia; Cinacalcet; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematinics; Hemoglobins; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Naphthalenes; Quality-Adjusted Life Years; Renal Dialysis; Vitamin D

2010
A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:4

    Topics: Anemia; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis

2011
Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease.
    Clinical nephrology, 2011, Volume: 76, Issue:2

    Topics: Anemia; Cinacalcet; Cohort Studies; Darbepoetin alfa; Drug Interactions; Erythropoietin; Female; Hematinics; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome

2011
The latest findings in basic and clinical nephrology science.
    Drug news & perspectives, 2005, Volume: 18, Issue:3

    Topics: Anemia; Cinacalcet; Clinical Trials as Topic; Humans; Kidney Diseases; Kidney Transplantation; Lanthanum; Naphthalenes; Renal Dialysis

2005